...
首页> 外文期刊>Alimentary pharmacology & therapeutics. >Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study
【24h】

Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study

机译:对胃肠炎静脉曲化的内窥镜筛查和慢性丙型肝炎患者变异的因子和因子相关的因素,2005 - 2016年,2005-2016:国家数据库联系研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Background Primary measures for preventing morbidity and mortality associated with bleeding gastroesophageal varices in cirrhotic patients include endoscopic screening. Aim To identify factors associated with (a) screening and (b) first hospital admission for variceal bleeding among cirrhotic hepatitis C virus (HCV) patients attending specialist care in Scotland. Methods The Scottish Hepatitis C Clinical Database was linked to national hospitalisation and deaths records to identify all chronic HCV patients diagnosed with compensated cirrhosis in 2005‐2016 (n?=?2741). The adjusted odds of being screened by calendar year period were estimated using logistic regression, and the adjusted hazard ratio (HR) of a first variceal bleed using Cox regression. Results About 34% were screened within the period starting 12?months before and ending 12?months after cirrhosis diagnosis. The proportion screened was stable in 2005‐2010 at 42%, declining to 37% in 2011‐2013 and 26% in 2014‐2016. Odds of screening were decreased for age‐groups 40 (OR?=?0.61, 95% CI: 0.48‐0.77) and 60+ years (OR?=?0.67, 95% CI: 0.48‐0.94), history of antiviral therapy (OR?=?0.70, 95% CI: 0.55‐0.89), and cirrhosis diagnosis in 2014‐2015, compared with 2008‐2010 (OR?=?0.67, 95% CI: 0.52‐0.86). Compared with 2008‐2010, there was no evidence for an increased/decreased relative risk of a first variceal bleed in any other period, but viral clearance was associated with a lower risk (HR?=?0.56, 95% CI: 0.32‐0.97). Conclusions Overall screening uptake following cirrhosis diagnosis was low, and the decline in recent years is of concern. The stable bleeding risk over time may be attributable both to ongoing prevention initiatives and to changing diagnostic procedures creating a patient pool with milder disease in more recent years.
机译:发明内容背景下肝硬化患者出血胃食管静脉曲张的预防发病率和死亡率的主要措施包括内窥镜筛查。目的旨在识别与(a)筛选和(b)肝硬化肝炎病毒(hcv)患者的静脉曲张出血的第一次医院入院的因素,参加苏格兰专家护理。方法苏格兰丙型肝炎临床数据库与国家住院和死亡记录相关联,以确定2005 - 2016年诊断患有补偿肝硬化的慢性HCV患者(N?= 2741)。使用逻辑回归估计由日历年期间筛选的调整后的几率,以及使用COX回归的第一个静脉曲张出血的调整后的危险比(HR)。结果约有34%的时间在12月12日起在12月开始前期和结束12月12月12日?肝硬化诊断后的月份。筛选的比例在2005 - 2010年稳定在42%,2011-2013的37%下降至2014 - 2016年的26%。年龄组的筛选的几率降低(或α= 0.61,95%CI:0.48-0.77)和60多年(或?=?0.67,95%CI:0.48-0.94),抗病史疗法(或?=?0.70,95%CI:0.55-0.89)和2014 - 2015年的肝硬化诊断与2008-2010(或?= 0.67,95%CI:0.52-0.86)相比。与2008-2010相比,在任何其他时期,第一个变种渗出的相对风险增加/减少了且病毒间隙较低的风险(HR?= 0.56,95%CI:0.32-0.97 )。结论肝硬化诊断后的整体筛选摄取性低,近年来的下降是关注的。随着时间的推移,稳定的出血风险可能是由于持续预防措施以及更换诊断程序,在近年来更近年来更换疾病的患者池。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号